• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清内皮细胞蛋白 C 受体水平与慢性肾脏病和终末期肾病患者亚临床动脉粥样硬化。

Serum Endocan Levels and Subclinical Atherosclerosis in Patients with Chronic Kidney and End-Stage Renal Diseases.

机构信息

Department of Internal Medicine, Faculty of Medicine (Girls) Al-Azhar University, Cairo, Egypt.

Department of Biochemistry, Faculty of Medicine Al Azhar University, Faculty of Medicine (Girls) Al-Azhar University, Cairo, Egypt.

出版信息

Int J Clin Pract. 2022 Jul 13;2022:4524637. doi: 10.1155/2022/4524637. eCollection 2022.

DOI:10.1155/2022/4524637
PMID:35936065
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9300358/
Abstract

RESULTS

HD and CKD groups had significantly higher endocan levels when compared with control group (median (IQR): 519.0 (202.3-742.0) versus 409.0 (245.3-505.3) and 273.0 (168.0-395.5) ng/L, respectively). Also, HD patients had significantly higher endocan levels when compared with CKD levels. HD patients had significantly higher carotid intima-media thickness (CIMT) when compared with CKD patients (median (IQR): 0.80 (0.80-0.90) versus 0.75 (0.73-0.75) mm, < 0.001). HD patients had significantly higher frequency of SCA when compared with CKD patients (46.7% versus 13.3%, =0.005). Patients with SCA had significantly higher hsCRP (median (IQR): 36.5 (26.8-43.5) versus 24.0 (15.8-29.0) mg/dl) and endocan levels (697.0 (528.3-974.8) versus 222.5 (158.8-565.8) ng/L) when compared with patients without SCA. ROC curve analysis of endocan for identification of SCA in HD patients showed that at a cutoff of 380.5 ng/L, endocan has an AUC of 0.862 with a sensitivity and specificity of 92.9% and 68.7%, respectively.

CONCLUSIONS

Serum endocan levels are related to SCA in HD patients. In addition, it is associated with the hyperinflammatory state in those patients.

摘要

结果

与对照组相比,HD 和 CKD 组的内皮素水平明显升高(中位数(IQR):519.0(202.3-742.0)比 409.0(245.3-505.3)和 273.0(168.0-395.5)ng/L)。此外,与 CKD 患者相比,HD 患者的内皮素水平明显升高。与 CKD 患者相比,HD 患者的颈动脉内膜中层厚度(CIMT)明显更高(中位数(IQR):0.80(0.80-0.90)比 0.75(0.73-0.75)mm,<0.001)。与 CKD 患者相比,HD 患者的 SCA 发生率明显更高(46.7%比 13.3%,=0.005)。与无 SCA 的患者相比,SCA 患者的 hsCRP(中位数(IQR):36.5(26.8-43.5)比 24.0(15.8-29.0)mg/dl)和内皮素水平(697.0(528.3-974.8)比 222.5(158.8-565.8)ng/L)明显更高。ROC 曲线分析显示,内皮素用于识别 HD 患者的 SCA 时,其截断值为 380.5ng/L,AUC 为 0.862,敏感性和特异性分别为 92.9%和 68.7%。

结论

血清内皮素水平与 HD 患者的 SCA 有关。此外,它与这些患者的高炎症状态有关。

相似文献

1
Serum Endocan Levels and Subclinical Atherosclerosis in Patients with Chronic Kidney and End-Stage Renal Diseases.血清内皮细胞蛋白 C 受体水平与慢性肾脏病和终末期肾病患者亚临床动脉粥样硬化。
Int J Clin Pract. 2022 Jul 13;2022:4524637. doi: 10.1155/2022/4524637. eCollection 2022.
2
The Association Between Endocan Levels and Subclinical Atherosclerosis in Patients With Type 2 Diabetes Mellitus.2型糖尿病患者体内内脂素水平与亚临床动脉粥样硬化的关联
Am J Med Sci. 2017 May;353(5):433-438. doi: 10.1016/j.amjms.2017.02.004. Epub 2017 Feb 22.
3
Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease.血浆内皮细胞蛋白聚糖水平与慢性肾脏病中的炎症、血管异常、心血管事件和生存有关。
Kidney Int. 2014 Dec;86(6):1213-20. doi: 10.1038/ki.2014.227. Epub 2014 Jul 2.
4
Subclinical atherosclerosis in psoriatic disease: relation to endocan, TNF-α, age of onset, and body fat.银屑病患者的亚临床动脉粥样硬化:与内脂素、TNF-α、发病年龄和体脂的关系。
Int J Dermatol. 2019 Apr;58(4):456-464. doi: 10.1111/ijd.14290. Epub 2018 Nov 23.
5
Serum markers for asymptomatic atherosclerosis in Egyptian psoriatic patients: study controlled by Doppler estimation of carotid intima-media thickness.埃及银屑病患者无症状动脉粥样硬化的血清标志物:通过颈动脉内膜中层厚度的多普勒估计进行对照研究。
Vasc Health Risk Manag. 2018 Jul 9;14:145-152. doi: 10.2147/VHRM.S164274. eCollection 2018.
6
Assessment of Endocan Serum Level in Patients with Behçet Disease: Relation to Disease Activity and Carotid Intima Media Thickness.评估 Behcet 病患者的血清内皮细胞水平:与疾病活动度和颈动脉内膜中层厚度的关系。
Egypt J Immunol. 2020 Jan;27(1):129-139.
7
Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation.家族性地中海热患者内皮功能障碍的评估:不对称二甲基精氨酸和内脂素水平与颈动脉内膜中层厚度和内皮依赖性血管舒张的关系。
Clin Rheumatol. 2017 Sep;36(9):2071-2077. doi: 10.1007/s10067-016-3532-2. Epub 2017 Jan 10.
8
Can the Serum Endocan Level Be Used as a Biomarker to Predict Subclinical Atherosclerosis in Patients with Prediabetes?血清内皮细胞蛋白 C 受体水平能否作为预测糖尿病前期患者亚临床动脉粥样硬化的生物标志物?
Arq Bras Cardiol. 2022 Oct;119(4):544-550. doi: 10.36660/abc.20210797.
9
Serum endocan as a predictive biomarker of cardiovascular risk in erectile dysfunction patients.血清内脂素作为勃起功能障碍患者心血管风险的预测生物标志物。
Andrologia. 2018 Dec;50(10):e13113. doi: 10.1111/and.13113. Epub 2018 Jul 23.
10
Serum endocan levels, carotid intima-media thickness and microalbuminuria in patients with newly diagnosed hypertension.血清内皮细胞黏附分子水平、颈动脉内膜中层厚度和新诊断高血压患者的微量白蛋白尿。
Clin Exp Hypertens. 2019;41(8):787-794. doi: 10.1080/10641963.2019.1652632. Epub 2019 Aug 7.

引用本文的文献

1
The predictive value of endocan as a novel biomarker: an umbrella study on meta-analyses.内皮糖蛋白作为一种新型生物标志物的预测价值:一项关于荟萃分析的综合研究。
Syst Rev. 2025 May 1;14(1):98. doi: 10.1186/s13643-025-02858-4.
2
Serum Endocan Levels as a Risk Factor for Peripheral Artery Disease in Non-Dialysis Patients with Chronic Kidney Disease Stages 3-5.血清内脂素水平作为3-5期慢性肾脏病非透析患者外周动脉疾病的危险因素
Medicina (Kaunas). 2025 Mar 24;61(4):577. doi: 10.3390/medicina61040577.
3
The Relationship between Vascular Biomarkers (Serum Endocan and Endothelin-1), NT-proBNP, and Renal Function in Chronic Kidney Disease, IgA Nephropathy: A Cross-Sectional Study.

本文引用的文献

1
Can Endocan Be a Novel Marker in the Diagnosis of Brucellosis?内脂素能否成为诊断布氏杆菌病的新型标志物?
Vector Borne Zoonotic Dis. 2022 Apr;22(4):232-237. doi: 10.1089/vbz.2021.0103. Epub 2022 Apr 11.
2
Endocan as a potential marker in diagnosis and predicting disease severity in COVID-19 patients: a promising biomarker for patients with false-negative RT-PCR.内脂素作为 COVID-19 患者诊断和预测疾病严重程度的潜在标志物:一种对 RT-PCR 假阴性患者有前途的生物标志物。
Ups J Med Sci. 2022 Jan 24;12. doi: 10.48101/ujms.v127.8211. eCollection 2022.
3
Endocan, a Soluble Marker of Endothelial Cell Activation Is a Molecular Marker of Disease Severity in Women with Preeclampsia.
血管生物标志物(血清内皮素和内脂素 1)、NT-proBNP 与慢性肾脏病 IgA 肾病患者肾功能的关系:一项横断面研究。
Int J Mol Sci. 2024 Sep 30;25(19):10552. doi: 10.3390/ijms251910552.
4
High circulating endocan in chronic kidney disease? A systematic review and meta-analysis.慢性肾脏病中循环内Endocan 水平升高?系统评价和荟萃分析。
PLoS One. 2023 Aug 9;18(8):e0289710. doi: 10.1371/journal.pone.0289710. eCollection 2023.
5
The Role of Endocan in Cardiometabolic Disorders.内卡蛋白在心脏代谢紊乱中的作用。
Metabolites. 2023 May 8;13(5):640. doi: 10.3390/metabo13050640.
6
Investigation of serum endocan and serglycin levels in obstructive sleep apnea.阻塞性睡眠呼吸暂停患者血清内皮细胞蛋白 C 受体和神经纤毛蛋白水平的研究。
Ir J Med Sci. 2023 Dec;192(6):2909-2915. doi: 10.1007/s11845-023-03360-3. Epub 2023 Apr 6.
内皮细胞活化的可溶性标志物内皮素是子痫前期妇女疾病严重程度的分子标志物。
Reprod Sci. 2022 Aug;29(8):2310-2321. doi: 10.1007/s43032-022-00858-6. Epub 2022 Feb 3.
4
Endocan alters nitric oxide production in endothelial cells by targeting AKT/eNOS and NFkB/iNOS signaling.内皮细胞蛋白聚糖通过靶向 AKT/eNOS 和 NFkB/iNOS 信号通路改变内皮细胞一氧化氮的产生。
Nitric Oxide. 2021 Dec 1;117:26-33. doi: 10.1016/j.niox.2021.09.006. Epub 2021 Sep 27.
5
Circulating Osteoprotegerin in Chronic Kidney Disease and All-Cause Mortality.慢性肾脏病中的循环骨保护素与全因死亡率
Int J Gen Med. 2021 Jun 9;14:2413-2420. doi: 10.2147/IJGM.S302251. eCollection 2021.
6
Endocan and Circulating Progenitor Cells in Women with Systemic Sclerosis: Association with Inflammation and Pulmonary Hypertension.系统性硬化症女性患者体内的内脂素与循环祖细胞:与炎症及肺动脉高压的关联
Biomedicines. 2021 May 11;9(5):533. doi: 10.3390/biomedicines9050533.
7
Endocan: A Novel Predictor of Endothelial Dysfunction in Silent Brain Infarction.内皮细胞蛋白聚糖:沉默性脑梗死内皮功能障碍的新型预测指标。
Angiology. 2021 Oct;72(9):850-854. doi: 10.1177/00033197211012135. Epub 2021 Apr 27.
8
Inflammatory markers in end-stage renal disease patients on haemodialysis.接受血液透析的终末期肾病患者的炎症标志物
J Med Biochem. 2020 Oct 2;39(4):481-487. doi: 10.5937/jomb0-25120.
9
Cleaved endocan acts as a biologic competitor of endocan in the control of ICAM-1-dependent leukocyte diapedesis.切割的内皮细胞蛋白可作为内皮细胞蛋白在控制 ICAM-1 依赖性白细胞渗出中的生物学竞争物。
J Leukoc Biol. 2020 May;107(5):833-841. doi: 10.1002/JLB.3AB0320-612RR. Epub 2020 Apr 9.
10
Endocan and a novel score for dyslipidemia, oxidative stress and inflammation (DOI score) are independently correlated with glycated hemoglobin (HbA) in patients with prediabetes and type 2 diabetes.内脂素以及一种用于评估血脂异常、氧化应激和炎症的新评分(DOI评分)与糖尿病前期和2型糖尿病患者的糖化血红蛋白(HbA)独立相关。
Arch Med Sci. 2019 Aug 27;16(1):42-50. doi: 10.5114/aoms.2019.87541. eCollection 2020.